Daewoong Co., Ltd. (KRX:003090)

South Korea flag South Korea · Delayed Price · Currency is KRW
27,550
-450 (-1.61%)
At close: Jun 5, 2025, 3:30 PM KST
67.17%
Market Cap 1.13T
Revenue (ttm) 1.97T
Net Income (ttm) 62.94B
Shares Out 40.89M
EPS (ttm) 1,539.51
PE Ratio 17.90
Forward PE 7.71
Dividend 200.00 (0.73%)
Ex-Dividend Date Dec 27, 2024
Volume 158,868
Average Volume 169,854
Open 27,700
Previous Close 28,000
Day's Range 26,750 - 28,350
52-Week Range 15,050 - 28,550
Beta 1.07
RSI 79.54
Earnings Date May 14, 2025

About Daewoong

Daewoong Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of pharmaceuticals in South Korea. It is also involved in the real estate rental business; provision of lifestyle-related disease prevention research, business management, public affairs, and facility management services; and processing and sale of food products. The company was formerly known as Daewoong Pharmaceutical Co., Ltd. and changed its name to Daewoong Co., Ltd. in 2002. Daewoong Co., Ltd. was founded in 1945 and is headquartered in Seongnam, South... [Read more]

Sector Healthcare
Founded 1945
Employees 356
Stock Exchange Korea Stock Exchange
Ticker Symbol 003090
Full Company Profile

Financial Performance

In 2024, Daewoong's revenue was 1.94 trillion, an increase of 6.79% compared to the previous year's 1.81 trillion. Earnings were 57.89 billion, a decrease of -62.08%.

Financial Statements

News

There is no news available yet.